Factors associated with the recurrence of choroidal neovascularization in pathologic myopia

被引:1
|
作者
Jing, Ruixia [1 ]
Bo, Yuxia [2 ]
Gao, Lei [3 ]
Wang, Zhen [4 ]
机构
[1] Shandong First Med Univ, Jinan, Peoples R China
[2] Wucheng Hosp Tradit Chinese Med, Dept Ophthalmol, Dezhou, Peoples R China
[3] Jinan 2nd Peoples Hosp, Dept Ophthalmol, Jinan, Peoples R China
[4] Shandong First Med Univ, Cent Hosp, Dept Ophthalmol, Jinan, Peoples R China
关键词
choroidal neovascularization; pathologic myopia; optical coherence tomography; OCT-angiography; recurrence; ELLIPSOID ZONE; VISUAL-ACUITY; RANIBIZUMAB; OUTCOMES; EYES; ANGIOGRAPHY;
D O I
10.3389/fmed.2022.968800
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeTo investigate the factors associated with the recurrence of pathologic myopia choroidal neovascularization (PM-CNV). MethodsForty-eight eyes of 48 patients with PM-CNV treated with conbercept at least 6 months of follow-up were included. Appearance of ellipsoid zone (EZ) and retinal pigment epithelium (RPE) observed on optical coherence tomography (OCT). Hyperreflective foci (HRF) height measured on OCT. Observation of CNV shape on OCT-angiography (OCTA). PM-CNV area measured on OCTA. To observe relationship between these factors and best corrected visual acuity (BCVA) and PM-CNV recurrence. ResultsThe 48 patients (48 eyes) with PM-CNV were divided into two groups: yielding a group of 20 eyes with type 1 and a group of 28 eyes with type 2. The BCVA of type 1 was better than type 2 before and after treatment (P < 0.005). Smaller HRF height (P < 0.001) and CNV area (P < 0.001) for type 1 than type 2. The appearance of EZ and RPE were intact (P < 0.001). Spearman correlation analysis found that final BCVA was significantly associated with baseline BCVA, HRF height, and appearance of EZ (P < 0.05). Binary logistics regression analysis revealed that PM-CNV recurrence was significantly correlated not only HRF height and CNV area, but also with appearance of EZ, and RPE (P < 0.05). ConclusionPM-CNV had a higher recurrence ratio. Baseline BCVA and clinical features play an important role for vision prognosis. Factors associated with PM-CNV recurrence include HRF height, CNV area, and changes in EZ and RPE structure.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] CANADIAN BURDEN OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: BASELINE CHARACTERISTICS OF PATIENTS
    Zaour, N.
    Heisel, O.
    Barbeau, M.
    Ma, P.
    VALUE IN HEALTH, 2013, 16 (07) : A504 - A504
  • [42] Pathologic myopia-related choroidal neovascularization: Treatment with radiation therapy.
    Milea, D
    Chiquet, C
    Mauget, M
    Martin, P
    Gerard, JP
    Koenig, F
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 468 - 468
  • [43] Choroidal neovascularization in pathological myopia
    Neelam, Kumari
    Cheung, Chiu Ming Gemmy
    Ohno-Matsui, Kyoko
    Lai, Timothy Y. Y.
    Wong, Tien Y.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2012, 31 (05) : 495 - 525
  • [44] Intravitreal bevacizumab for the treatment of choroidal neovascularization associated with pathological myopia
    Rheaume, Marc-Andre
    Sebag, Mikael
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2008, 43 (05): : 576 - 580
  • [45] CHOROIDAL THICKNESS IN PATHOLOGIC MYOPIA
    Farinha, Claudia
    Baltar, Alda
    Nunes, Sandrina
    Santos, Ana Rita
    Cachulo, Maria da Luz
    Pires, Isabel
    Figueira, Joao
    Silva, Rufino
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [46] LONG-TERM RESULTS OF PHOTODYNAMIC THERAPY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION WITH PATHOLOGIC MYOPIA
    Giansanti, Fabrizio
    Virgili, Gianni
    Donati, Maria Carla
    Giuntoli, Matteo
    Pieretti, Giulia
    Abbruzzese, Giacomo
    Menchini, Ugo
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (08): : 1547 - 1552
  • [47] SIX-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA
    Kasahara, Kaori
    Moriyama, Muka
    Morohoshi, Kei
    Yoshida, Takeshi
    Simada, Noriaki
    Nagaoka, Natsuko
    Yokoi, Tae
    Shinohara, Kosei
    Kaneko, Yuichiro
    Suga, Mitsuki
    Ohno-Matsui, Kyoko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1055 - 1064
  • [48] FIVE-YEAR OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA
    Onishi, Yuka
    Yokoi, Tae
    Kasahara, Kaori
    Yoshida, Takeshi
    Nagaoka, Natsuko
    Shinohara, Kosei
    Kaneko, Yuichiro
    Suga, Mitsuki
    Uramoto, Kengo
    Ohno-Tanaka, Akiko
    Ohno-Matsui, Kyoko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (07): : 1289 - 1298
  • [49] Nine-Year Outcome of Ranibizumab Monotherapy for Choroidal Neovascularization Secondary to Pathologic Myopia
    Pastore, Marco R.
    Capuano, Vittorio
    Bruyere, Elsa
    Miere, Alexandra
    Corbelli, Eleonora
    Querques, Lea
    Tognetto, Daniele
    Bandello, Francesco
    Querques, Giuseppe
    Souied, Eric H.
    OPHTHALMOLOGICA, 2018, 239 (2-3) : 133 - 142
  • [50] Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia
    Hernandez-Rojas, Myriam L.
    Quiroz-Mercado, Hugo
    Dalma-Weiszhausz, Jose
    Fromow-Guerra, Jans
    Amaya-Espinosa, Andres
    Solis-Vivanco, Adriana
    Martinez-Castellanos, Maria Ana
    Aiello, Lloyd P.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (06): : 707 - 712